Lawrence Erik Kurzius, a director at McCormick & Co Inc (NASDAQ:MKC), filed a Form 4 on August 12, 2026, reporting the exercise of stock options and a same-day sale of common shares on August 10, 2026.

Key Highlights

  • Option exercise: Kurzius exercised options covering 205,538 shares of Common Stock - Voting at an exercise price of $49.025 per share on August 10, 2026.
  • Same-day sale: 205,538 shares of Common Stock - Voting were disposed of at a price of $52.6871 per share on August 10, 2026.
  • Post-transaction ownership (direct): Kurzius directly held 296,992 shares following the reported transactions.
  • Option expiration date: The exercised options carried an expiration date of March 29, 2027, and were first exercisable March 29, 2018.
  • No purchase price required: According to the filing's footnote, the option was "exercised; no purchase price required."

Kurzius Option Exercise and Share Disposal Details at McCormick

According to the Form 4 filed on August 12, 2026, Lawrence Erik Kurzius, identified as a director of McCormick & Co Inc (NASDAQ:MKC), engaged in two linked transactions on August 10, 2026. First, Kurzius exercised options (transaction code M) to acquire 205,538 shares of Common Stock - Voting at a conversion or exercise price of $49.025 per share. The filing notes the option carried a zero price of derivative security, with a footnote stating "Option exercised; no purchase price required."

In the same session, the filing reports a disposition (transaction code S) of 205,538 shares of Common Stock - Voting at $52.6871 per share. Prior to the exercise, the filing indicates Kurzius held 502,530 shares directly; following both transactions, his direct beneficial ownership stood at 296,992 shares. The underlying options, now fully disposed of, were originally exercisable from March 29, 2018, with an expiration date of March 29, 2027, and zero derivative securities remain beneficially owned following the transaction, according to the filing.

The Form 4 was signed by Jeffery D. Schwartz as Attorney-in-Fact on August 12, 2026. The filing does not indicate that this transaction was made pursuant to a Rule 10b5-1(c) plan, as the relevant checkbox was not marked.

What Was Disclosed

The filing reports a director's exercise of 205,538 stock options at $49.025 per share and a same-day sale of the resulting 205,538 shares at $52.6871 per share, leaving the director with 296,992 directly held shares.